Blueprint Medicines Aktie
105,40
EUR
-0,10
EUR
-0,09
%
110,07
USD
+6,09
USD
+5,86
%
Werbung
Blueprint Medicines Aktie Analyse
| 18.07.19 | Blueprint Medicines Buy | Deutsche Bank AG | |
| 29.09.17 | Blueprint Medicines Buy | BTIG Research | |
| 05.04.17 | Blueprint Medicines Outperform | Wedbush Morgan Securities Inc. |
Werbung